“We are pleased that this partnership amplifies our ability to provide tertiary care, yet remain physician led and community focused.”Įxcela officials declined to comment further. “The new system will provide additional services and better access to those services,” said Ken DeFurio, president and CEO of Butler Health System. Further discussions, along with regulatory and final board approvals, could take months to complete. Specific details weren’t released Wednesday. Pleasant, Latrobe Hospital in Latrobe and its flagship Westmoreland Hospital in Greensburg - with the two Butler Health System hospitals - Butler Memorial Hospital in Butler and Clarion Hospital in Monroe Township, Clarion County. The yet-to-be-named health system would bring together Excela’s three locations - Frick Hospital in Mt. When combined, the system is expected to generate more than $1 billion in revenue, employ 7,300 people and have more than 1,000 physicians and practitioners to serve about 750,000 people in Butler, Clarion and Westmoreland counties. The combined organization “will present the requisite scale to accelerate and elevate its relevancy … in the region’s highly competitive health care marketplace,” which is largely dominated by the health giants UPMC and Highmark Health’s Allegheny Health Network, according to a joint statement from Excela and Butler Health. “In doing so, we can enhance access to care, decrease the cost of care and continue to focus on providing improved experiences and outcomes for patients.” “We believe strongly that our new partnership will extend our intellectual and financial capital,” John Sphon, Excela Health chief executive officer, said in a prepared statement. Sources: Excela Health, Butler Health System, UPMC, Allegheny Health Network.Ī third Southwestern Pennsylvania health care conglomerate is in the works, as Excela Health and Butler Health System on Wednesday announced an intent to merge. Number of facilities: 14 hospitals and more than 200 primary and specialty care practices at more than 300 locations.Īnnual revenue: $154 million for the year ending Dec. Number of facilities: 40 hospitals, 800 doctors offices and outpatient sites, 28 senior communitiesĪnnual revenue: $24 billion in operating revenue in 2021Įmployees: 2,600 physicians and more than 21,000 employees. Operating income: Saw an operating loss of $8.2 million during the same period.Įmployees: 4,900 employed doctors, 92,000 staff members Number of facilities: Two hospitals: Butler Memorial and Clarion, 72 outpatient locationsĪnnual revenue: $405.1 million in operating revenue in the third quarter of fiscal year 2022 Operating income: Saw an operating loss of $10.5 million, for the same period.Įmployees: More than 3,000 employees, 270 providers Quality improvement efforts therefore need to be focused on both discharge planning and outpatient care.Employees: 700 physicians, more than 4,800 employees and 797 volunteersĪnnual revenue: $500.1 million in operating revenues for the nine months ending on March 31 Patients not discharged with ACEIs are unlikely to be started as outpatients. Patients with a discharge order for ACEIs were more likely to fill a prescription within 30 days postdischarge (hazard ratio 10.93, 95% confidence interval 5.28, 22.61, for patients with depressed EF).įor patients with HF who are discharged while taking ACEIs, there is a significant decline in use after discharge. In contrast, for patients with no discharge order for ACEIs, only 12.7%/12.0% (depressed EF/total cohort) had filled such a prescription by 30 days and 12.5%/18.8% were current users at 365 days postdischarge. Overall 81.2%/77.1% (depressed EF/total cohort) of survivors discharged with ACEIs had filled a prescription by 30 days postdischarge only 66.3%/63.3% were current users at 365 days. Sixty-seven percent of patients with depressed EF and 55% of the total cohort were discharged with ACEIs. To assess the factors associated with filling an ACEI prescription in the 30 days postdischarge and the proportion of patients who filled such prescriptions subsequently up to 365 days postdischarge, we studied 219 patients with depressed ejection fraction (EF) specifically and 960 HF patients in general. The benefits of such quality improvement attempts will be limited if therapy is not continued long-term. This study was designed to assess outpatient angiotensin-converting enzyme inhibitor (ACEI) use after heart failure (HF) hospitalization.Īssuring therapy with ACEIs at discharge after HF hospitalization is a key Medicare quality measure.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |